logo

Amylyx Pharmaceuticals Inc (AMLX) Stock: A Year of Market Fluctuations

PNC Stock

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Amylyx Pharmaceuticals Inc’s current trading price is -82.70% away from its 52-week high, while its distance from the 52-week low is 113.33%. The stock’s price range for this time frame has been between $1.58 and $19.42. The trading volume of the company’s shares in the Healthcare reached around 0.75 million for the day, which was evidently lower than the average daily volume of 0.83 million over the last three months.

The stock market performance of Amylyx Pharmaceuticals Inc has been fairly unsteady. Over the last year, the company’s stock hit its highest at $19.42 on 03/06/24, while the lowest price during the same time frame was $1.58, recorded on 06/17/24.

How Financial Performance Impacts Market Capitalization

Amylyx Pharmaceuticals Inc (AMLX) has experienced a quarterly decline of -39.35% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 287.92M and boasts a workforce of 123 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 4.29, with a change in price of +0.10. Similarly, Amylyx Pharmaceuticals Inc recorded 1,117,855 in trading volume during the last 100 days, posting a change of +3.07%.

How AMLX’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for AMLX stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.00.

AMLX Stock Stochastic Average

Amylyx Pharmaceuticals Inc’s raw stochastic average for the past 50 days is currently at 48.10%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 55.88%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 32.79% and 28.43%, respectively.

AMLX Stock Price Performance Analysis

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The metric has seen a significant loss of -11.11% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 51.35%. Over the past 30 days, the price of AMLX has leaped by -1.75%. And in the last five days, it has surged by 5.00%.

Most Popular